Skip to content
10-Q

Quarterly Report

Aurinia Pharmaceuticals Inc. AUPH

0001600620-25-000106

← back to feed
Filed
Nov 4, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 3, 2025 131.84M sh
Shares Diluted Q3 2025 · Sep 30, 2025 136.01M sh
Shares Diluted Q3 2025 · Sep 30, 2025 138.96M sh
Shares Diluted Q3 2025 · Sep 30, 2024 145.65M sh
Shares Diluted Q3 2025 · Sep 30, 2024 145.01M sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $98.16M
Stock Repurchased Q3 2025 · Sep 30, 2024 $18.44M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $89.99M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $14.27M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $72.89M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $36.63M
Stockholders Equity Q3 2025 · Sep 30, 2025 $365.77M
Stockholders Equity Q3 2025 · Jun 30, 2025 $335.3M
Stockholders Equity Q3 2025 · Mar 31, 2025 $350.19M
Stockholders Equity Q3 2025 · Dec 31, 2024 $377.48M
Stockholders Equity Q3 2025 · Sep 30, 2024 $388M
Stockholders Equity Q3 2025 · Jun 30, 2024 $364.62M
Stockholders Equity Q3 2025 · Mar 31, 2024 $359.48M
Stockholders Equity Q3 2025 · Dec 31, 2023 $377.95M
Current Liabilities Q3 2025 · Sep 30, 2025 $76.22M
Current Liabilities Q3 2025 · Dec 31, 2024 $97.76M
Total Liabilities Q3 2025 · Sep 30, 2025 $161.76M
Total Liabilities Q3 2025 · Dec 31, 2024 $173.17M
Current Assets Q3 2025 · Sep 30, 2025 $438.74M
Current Assets Q3 2025 · Dec 31, 2024 $446.6M
Total Assets Q3 2025 · Sep 30, 2025 $527.53M
Total Assets Q3 2025 · Dec 31, 2024 $550.65M
Eps Diluted Q3 2025 · Sep 30, 2025 $0.23
Eps Diluted Q3 2025 · Sep 30, 2025 $0.55
Eps Diluted Q3 2025 · Sep 30, 2024 $0.10
Eps Diluted Q3 2025 · Sep 30, 2024 $0.03
Eps Basic Q3 2025 · Sep 30, 2025 $0.24
Eps Basic Q3 2025 · Sep 30, 2025 $0.57
Eps Basic Q3 2025 · Sep 30, 2024 $0.10
Eps Basic Q3 2025 · Sep 30, 2024 $0.03
Rd Expense Q3 2025 · Sep 30, 2025 $8.44M
Rd Expense Q3 2025 · Sep 30, 2025 $21.61M
Rd Expense Q3 2025 · Sep 30, 2024 $3.05M
Rd Expense Q3 2025 · Sep 30, 2024 $12.68M
Net Income Q3 2025 · Sep 30, 2025 $31.55M
Net Income Q3 2025 · Sep 30, 2025 $76.41M
Net Income Q3 2025 · Jun 30, 2025 $21.51M
Net Income Q3 2025 · Mar 31, 2025 $23.34M
Net Income Q3 2025 · Sep 30, 2024 $14.35M
Net Income Q3 2025 · Sep 30, 2024 $4.32M
Net Income Q3 2025 · Jun 30, 2024 $722K
Net Income Q3 2025 · Mar 31, 2024 −$10.75M
Operating Income Q3 2025 · Sep 30, 2025 $29.75M
Operating Income Q3 2025 · Sep 30, 2025 $71.68M
Operating Income Q3 2025 · Sep 30, 2024 $11.75M
Operating Income Q3 2025 · Sep 30, 2024 −$3.02M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $8.18M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $23.87M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $6.04M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $22.7M
Revenue Q3 2025 · Sep 30, 2025 $73.47M
Revenue Q3 2025 · Sep 30, 2025 $205.94M
Revenue Q3 2025 · Sep 30, 2024 $67.77M
Revenue Q3 2025 · Sep 30, 2024 $175.27M